Replies to post #2101 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

Update on ENTA’s HBV development plan:

Based on yesterday’s CC, ENTA will not advance the EDP-514/nuc 2-drug combination into phase-2, but rather will look to find a suitable third agent before proceeding.

Thanks Dew. I haven't had a chance to listen to or read the CC. Any word on how long of a time frame they estimate that it will be until their third agent could enter safety trials?

[DewDiligence]

More on the same topic (ENTA's HBV program):

https://twitter.com/DewDiligence/status/1463579276842881034